Deductible ranges help exclude those kinds of expenditures that are affordable and that people should be paying for out of pocket.
Those are alternative ways of doing this. Not just the private sector does it, but of course, countries such as France have much higher expenditures on pharmaceuticals and much lower rates of growth in their overall health expenditures. I think we should be thinking about drug expenditures in a bigger envelope here in terms of the entire envelope of health expenditures and the impact of drugs on that envelope.